Trial Profile
The Use of Low-Dose Carvedilol to Improve Hypoglycemia Awareness in Patients With Type 1 Diabetes Mellitus
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary)
- Indications Hypoglycaemia
- Focus Therapeutic Use
- 19 Aug 2020 Status changed from recruiting to discontinued.
- 22 Apr 2019 Status changed from not yet recruiting to recruiting.
- 06 Mar 2019 Planned number of patients changed from 20 to 21.